CD276 and cancer: It has been reported that the downstream of Akt protein, Bcl-2, is involved in the anti-apoptotic process of a variety of cancer cells, leading to a decrease in cytotoxicity and drug resistance, B7-H3 upregulates the expression of Bcl-2 and promotes drug resistance [102,103].